
Sign up to save your podcasts
Or


In this episode of IMPACT Medicom’s podcast series on Precision Medicine in Oncology we discuss:
· The BC OncoPanel, a comprehensive genomic profiling (CGP) test available to patients with some cancers in British Columbia;
· The challenges for including CGP in laboratory budgets;
· The information exchange needed between stakeholders to accelerate access to CGP; and
· How IMPACT Medicom’s CGP prioritization report can provide decision-makers with a framework for implementing CGP testing.
Our guests:
Dr. Howard Lim is a Medical Oncologist at BC Cancer Agency and Clinical Associate Professor in the Faculty of Medicine at the University of British Columbia. He completed his medical oncology training at the BC Cancer Agency and received additional training at the Oregon Health Sciences University, specializing in gastrointestinal malignancies. Dr. Lim is actively involved in clinical trials, ethics, and genomic-based research.
Jim Slater [MLT(ART), BSc, MBA] began his career as a medical laboratory technician in BC and has since worked in all four Western provinces in the area of diagnostic services. His past leadership roles include Executive Director of all diagnostics in Saskatchewan, Chief Executive Officer of all diagnostic services in Manitoba, and most recently, Chief Provincial Diagnostics Officer at the Provincial Health Services Authority in BC. Jim currently provides Health System and Business Consulting services, with expertise in precision medicine (genomics), value-based healthcare, innovation and resource stewardship, research, and business development.
Howard and Jim both served as steering committee members on IMPACT Medicom’s CGP prioritization report. The full report can be downloaded at:
https://www.impactmedicom.com/publications/reports.
This podcast episode is sponsored by AstraZeneca Canada.
If you enjoy our podcast, please review and subscribe. For more podcasts, papers, and medical education programs, visit our website at: http://www.impactmedicom.com.
Welcome to our podcast series on precision medicine in oncology. In this first episode of the series, we discuss the importance of comprehensive genomic profiling (CGP) as a critical tool for treating patients with advanced solid tumors.
Included is a discussion of:
Our guest:
Dr. Sandeep Sehdev is a Medical Oncologist and Clinical Investigator at the Ottawa Hospital Cancer Centre. Dr. Sehdev served as a steering committee member in the development of the CGP report and is passionate about medical education, the application of technology in oncology, and patient advocacy.
If you enjoy our podcast, please review and subscribe. For more podcasts, papers, and medical education programs, visit our website at: http://www.impactmedicom.com.
In this episode, we discuss the use of Bruton’s Tyrosine Kinase (BTK) inhibitors for the treatment of patients with chronic lymphocytic leukemia (CLL).
Included is a discussion of:
Our guest:
Dr. Carolyn Owen is an Associate Professor in the Division of Hematology & Hematological Malignancies at the University of Calgary. She completed her internal medicine training in Ottawa, followed by Hematology training in Vancouver and a research fellowship in molecular genetics at Barts and the London School of Medicine. Her current clinical interests are in the areas of low-grade lymphoma and chronic lymphocytic leukemia (or CLL) and she is the local principal investigator at the Tom Baker Cancer Centre for a number of clinical trials focusing on these areas.
Funding for this episode provided by AstraZeneca, Canada. If you in enjoy our podcast, please review and subscribe. For more podcasts, papers, and medical education programs, visit our website at: http://www.impactmedicom.com.
In this episode we discuss the management of CLL patients during the COVID-19 pandemic.
Included is a discussion of:
Our guest:
Dr. Pavic is a Medical Oncologist and Chief of the Hemato-Oncology department at the Centre intégré universitaire de santé et de services sociaux de l’Estrie – Centre Hospitalier Universitaire de Sherbrooke and an assistant professor in the Faculty of Medicine and Health Sciences at the Université de Sherbrooke.
Guidelines
**If you enjoy our podcast, please take the time to rate our podcast and subscribe**
For more great podcasts and other features, visit our website at: www.impactmedicom.com.
On today’s podcast episode, we discuss the virtual management of patients with inflammatory arthritis.
We are joined by:
Our episode includes a discussion of:
**If you enjoy our podcast, please take the time to rate our podcast and subscribe**
For more great podcasts and other features, visit our website at: www.impactmedicom.com.
In this episode, we discuss the opioid epidemic in Canada and the use of naloxone, a life-saving drug that is used to prevent death from opioid overdose, with pharmacists: Dr. Ross Tsuyuki and Mark Barnes.
Our episode includes a discussion of:
**If you enjoy our podcast, please take the time to rate our podcast and subscribe**
For more great podcasts and other features, visit our website at: www.impactmedicom.com.
Dr. Ray Deonandan is a Canadian epidemiologist, assistant director, and associate professor at the University of Ottawa. In this episode, we discuss how we can exercise safely during the COVID-19 epidemic as the cold weather approaches.
**If you enjoy our podcast, please take the time to rate our podcast and subscribe**
For more great podcasts and other features, visit our website at: www.impactmedicom.com.
From the publisher's feed
We are a medical communications company with a passion for developing high-quality content. We write & design content for healthcare professionals and patients in a variety of therapeutic…

112,262 Listeners